FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Aneurysm Treatment Market Overview:

According to FutureWise analysis the market for aneurysm treatment is expected to register a CAGR of 8.22% from 2023-2031.

An aneurysm is an outgrowth in the wall of an artery. It is formed when there's a weakened area in the artery. If not treated, it can burst open, causing internal bleeding, blood clots, and obstructing blood flow in the artery. A rupture or clot can be life-threatening depending upon the area where it is generated. Aneurysms do not show any cause of pain and often go unnoticed unless a break can be seen, which can be fatal and lead to a hazardous situation. Diagnosis typically involves imaging tests like CT scans, CT or MRI angiography, and ultrasound. Classifications of aneurysms are based on their size and formation, including fusiform, saccular, mycotic, and pseudoaneurysms.

Management and treatment strategies aim to prevent aneurysm rupture. Depending on the aneurysm's type, location, and size, treatments may encompass medication to improve blood flow, control cholesterol, and lower blood pressure. Large aneurysms at risk of bursting may necessitate surgery, such as endovascular aneurysm repair (EVAR), open surgery, endovascular coiling (for cerebral aneurysms), microvascular clipping (for cerebral aneurysms), or catheter embolization. Early detection and appropriate treatment play crucial roles in managing aneurysms effectively.

FutureWise Market Research has published a report that provides an insightful analysis of Aneurysm Treatment Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Aneurysm Treatment Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

Major players included in the Aneurysm Treatment Market:

Penumbra
Terumo Medical Incorporated
Medtronic Plc
Phenox GmbH B. Braun Melsungen AG
Stryker
Raumedic AG
DePuy Synthes
Integra Life Sciences Corporation
Orsan Medical Technologies
Spiegelberg GmbH
MicroPort Scientific Corporation
Codman
Shurtleff, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Development in Aneurysm Treatment Market:

In September of 2022, the CorPath GRX Neurovascular System by Siemens Healthineers successfully conducted 94% of its endovascular procedures using robotic assistance, with no need for the surgeon to transition to manual intervention during the operation.
In June 2022, Medtronic India introduced the fourth-generation flow diverter, Pipeline Vantage with Shield Technology, which received Conformité Européenne (CE) marking. This advanced device is designed for the endovascular treatment of brain aneurysms.

Major drivers for the market growth are the upsurge in the prevalence of diseases like hypertension and stroke, fostering market growth. Ever-rising technological advancements and innovations are also a growth factor. The increasing recognition of the advantages of minimally invasive procedures is fueling the market's expansion. Growing awareness about the aneurysms and proactive screening initiatives lead to early detection and treatment, contributing to market expansion. Improved imaging techniques such as CT angiography and magnetic resonance angiography help in early and precise diagnosis, enabling the cure in time and patient safety, thus propelling the market growth. The government is organizing awareness programs, and non-government organizations are helping people become more knowledgeable about the disease and its treatment modalities, fueling the market growth.

However, the market is affected by significant restraints, such as a need for more awareness in underdeveloped nations. Also, the lack for qualified and skilled medical professionals’ hampers market growth as they are not readily available everywhere and are limited to the big cities. High cost is a significant restraint for this market as the surgical procedures are very costly and hence are less affordable to the lower socioeconomic strata of the population, thus hampering the market growth. Invasive procedures carry some risks and complications that may make people ignorant of the procedures and are declining the market growth.

Aneurysm Treatment Market Segmentation:

By Product Type

Surgical Clipping
Endovascular Coiling
Flow diverters

By End User

Hospitals
Neurological Centres

By Region

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America holds the largest market share due to the well-established health infrastructure, early adoption of technological advancements, high healthcare expenditure, adoption of minimally invasive procedures, and growing prevalence of hypertensions and strokes. Whereas Asia-Pacific is a rapidly growing market due to the majority of increasing public awareness about aneurysms, expanded access to healthcare services and improvised healthcare infrastructure are propelling the market growth in this region. In addition, government initiatives are playing a significant role in raising funds and promoting advanced healthcare technologies.

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global Aneurysm Treatment Market By Product Type, By End User, and By Region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies.

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1. Years Considered for the Study
  3.2. Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1. Secondary Data
  1.1.1. Key Data from Secondary Sources
  1.2. Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Global Aneurysm Treatment Market Variables, Trends and Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Global Aneurysm Treatment Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Aneurysm Treatment Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Aneurysm Treatment Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Global Aneurysm Treatment Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Surgical Clipping
  2. Endovascular Coiling
  3. Flow diverters
8. Global Aneurysm Treatment Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Hospitals
  2. Neurological Centres
9. North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2023-2031
10. Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2023-2031
11. Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2023-2031
12. Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
13. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Saudi Arabia
  2.2. UAE
  2.3. South Africa
  2.4. Egypt
  3. Market Size (USD Million) Forecast for MEA 2023-2031
14. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
- 1. Penumbra
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Terumo Medical Incorporated
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Medtronic Plc
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. Phenox GmbH B. Braun Melsungen AG
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. Stryker
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. Raumedic AG
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. DePuy Synthes
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Integra Life Sciences Corporation
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. Orsan Medical Technologies
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. Spiegelberg GmbH
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
  11. MicroPort Scientific Corporation
  11.1. Company Overview
  11.2. Product Portfolio
  11.3. SWOT Analysis
  11.4. Financial Overview
  11.5. Strategic Overview
  12. Codman
  12.1. Company Overview
  12.2. Product Portfolio
  12.3. SWOT Analysis
  12.4. Financial Overview
  12.5. Strategic Overview
  13. Shurtleff, Inc.
  13.1. Company Overview
  13.2. Product Portfolio
  13.3. SWOT Analysis
  13.4. Financial Overview
  13.5. Strategic Overview
16. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated
  by administrations
  5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients